The £52 million investment in London hopes to accelerate healthtech innovation by connecting startups to the wider healthcare ecosystem.
After £52 million investment, Hale House has been developed in the Harley Street Health District to be a hub for healthtech.
Developed by the Howard de Walden Estate and operated in partnership with Spacemade, Hale House spans three buildings: 19 Portland Place, 76-78 Portland Place and 42 Portland Place in Marylebone, London.
Hale House provides a range of workspaces all designed to promote collaboration among HealthTech innovators. The development offers an array of state-of-the-art amenities, including media production facilities, a wellness room and a rooftop garden terrace.
The hub wants to accelerate healthtech innovation by connecting startups to an ecosystem of more than 2,500 healthcare professionals, testing facilities and industry leaders through networking events.
“By investing in health innovation, we have created spaces that will push the boundaries of emerging technologies and help those involved in ground-breaking research,” said Mark Kildea, chief executive of The Howard de Walden Estate.
The Harley Street Health District represents 40% of London’s independent healthcare market and 10% of the UK market. It is home to healthcare providers, including HCA, Cleveland Clinic, Mayo Clinic and Cedars-Sinai, along with leading UK institutions such as The Royal Marsden, Guy’s and St Thomas’, UCLH, and Moorfields.
Hale House has already secured several partnerships, including UCLPartners, one of the world’s largest academic health science organisations; the NHS Innovation Accelerator, a national fellowship programme supporting innovators to scale; and One HealthTech, a volunteer-led, global community of health innovators which champions diversity and inclusion.
